Yale Medicine School: Study of Brain at Single-cell Resolution in Gaucher Disease Finds Key Role of Neuroinflammation
August 17, 2022
August 17, 2022
NEW HAVEN, Connecticut, Aug. 17 (TNSjou) -- Yale School of Medicine issued the following news:
A study by Yale scientists provides insights that could lead to new therapies for individuals with Gaucher disease (GD), while offering new understanding into the study of other diseases, including Parkinson's. This breakthrough research in the study of forms of Gaucher disease that cause neurodegeneration (nGD) has implications for individuals with rare diseases such as Gaucher, and . . .
A study by Yale scientists provides insights that could lead to new therapies for individuals with Gaucher disease (GD), while offering new understanding into the study of other diseases, including Parkinson's. This breakthrough research in the study of forms of Gaucher disease that cause neurodegeneration (nGD) has implications for individuals with rare diseases such as Gaucher, and . . .